Number of patients | 70 |
---|---|
Number of treatment cycles | 562 |
 Range | 1-34 |
 Mean | 8 |
Reason for termination of HAI | Â |
 Disease progression (intrahepatic n=11, extrahepatic n=16, both n=17) | 44 (63%) |
 Chemotherapy-related toxicity | 12 (17%) |
 Port complication | 5 (7%) |
 Post-progression HAI | 4 (6%) |
 Refusal | 4 (6%) |
 Loss of follow up | 1 (1%) |
Port complications per patient | Â |
 ≥1 complication | 21 (30%) |
 ≥3 complications | 3 (4%) |
 ≥ 1 revision | 15 (21%) |